A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) (NCT06585787)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.
Who can join: Review the eligibility criteria below.
Location: Local Institution - 1227 — Chandler, Arizona
Age range: 55 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (293 Sites)
Showing the first 25 of 293 sites.
- Local Institution - 1227 — Chandler, Arizona
- Gilbert Neurology Partners - PLLC - Avacare — Gilbert, Arizona
- Banner Alzheimer's Institute — Phoenix, Arizona
- Local Institution - 1220 — Scottsdale, Arizona
- Advanced Research Center, Inc. — Anaheim, California
- Inland Psychiatric Medical Group (IPMG)-Chino — Chino, California
- Local Institution - 1230 — Long Beach, California
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC) — Los Angeles, California
- Local Institution - 1219 — Los Angeles, California
- Local Institution - 1001 — Orange, California
- Local Institution - 1228 — Orange, California
- Local Institution - 1043 — Pasadena, California
- Local Institution - 1213 — Rancho Cucamonga, California
- University of Connecticut Health Center — Farmington, Connecticut
- Local Institution - 1225 — Atlantis, Florida
- Envision Trials LLC — Bonita Springs, Florida
- Local Institution - 1138 — Cutler Bay, Florida
- Arrow Clinical Trials — Daytona Beach, Florida
- Local Institution - 1224 — Deerfield Beach, Florida
- Local Institution - 1164 — Doral, Florida
- Local Institution - 1264 — Gulf Breeze, Florida
- Local Institution - 1120 — Hialeah, Florida
- Local Institution - 1237 — Hialeah, Florida
- Local Institution - 1229 — Homestead, Florida
- Local Institution - 1040 — Lady Lake, Florida
📞 Contact the Study Coordinator
Phone: (855) 907-3286
Email: Clinical.Trials@bms.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease
- The Use of Memantine for Prevention of Alzheimer's Disease — Charlottesville, Virginia
- Investigation of Inflammation Using [C-11]-CS1P1 — St Louis, Missouri
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia — Palo Alto, California
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) — Gilbert, Arizona
- High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease — Cambridge, Massachusetts
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Phoenix, Arizona
Explore by condition: All Alzheimer Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.